CERS Q2 2024 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$358M

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$45M+16.0% YoY

Gross Profit

$25M54.7% margin

Operating Income

-$4M-8.5% margin

Net Income

-$6M-12.8% margin

EPS (Diluted)

$-0.03

QoQ Revenue Growth

+17.5%

Cash Flow

Operating Cash Flow

$401,000

Free Cash Flow

$360,000

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$185M

Total Liabilities

$135M

Stockholders' Equity

$50M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$45M	$39M	+16.0%
Gross Profit	$25M	$21M	+15.6%
Operating Income	-$4M	-$12M	+67.0%
Net Income	-$6M	-$13M	+56.5%

Revenue Segments

Product

$45M89%

Government Contract

$5M11%

Geographic Segments

North America

$31M68%

Europe Middle East And Africa

$14M30%

Other

$558,0001%